BlackRock Just Hit $15.3 Trillion. The Stock Is Still Off Its High.
Monetary Elite A record-breaking Q2 beat just sent shares surging. Here's why the real story runs deeper.
Business
The Trade Desk Is Down 84% From Its Peak. The CEO Just Bought ~$150M.
TTD is the most debated fallen stock of 2026. Q2 earnings in August could settle it.
VRT Is Up 84% This Year. The Real Trade Is What Happens July 29.
Vertiv ended 2025 with a $15.0B order backlog and is widely expected to report Q2 earnings on July 29. Put…
Delta Beat the Quarter. The Stock Fell Anyway. Here’s What the Market Is Missing.
Premium revenue just surpassed coach for the first time. That detail changes the entire investment story.
GOOGL Reports July 22. The Stock Is Down About 10% From Its Post–Q1 Peak—and the Antitrust Risk Still Isn’t Cleanly Priced.
A ~$460B cloud backlog is real. So is a remedies decision that could reshape Google’s search and ad economics.
Big Pharma Has $1.3 Trillion to Spend. The Clock Is Running.
A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.
SpaceX Is Now Public. The Real Question Starts Now.
SPCX went public at $135 and hit $225 in four days. Now it's back near $157. So what is this…
Carlisle Just Went Hostile. The Building Materials Sector Will Never Be the Same.
A $10 billion unsolicited bid is the opening move in a much bigger consolidation wave.
Wall Street Just Raised Its Targets. The Number That Should Worry You Is Not the S&P Level.
JPMorgan sees 7,800. The real risk is hidden inside the earnings math.
NKE Reports June 30. The Stock Is Down 40% and Expectations Are Already in the Gutter.
Options traders are pricing an 8.5% move. The real question is what happens to gross margin.